Recent PRLB Stock Price | PRLB Stock Predictions | |
$40.04 | +0.72% |
$40.33 |
Recent PRLB Analyst Ratings Breakdown, Making PRLB Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 2 | 2 | 2 | 2 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.2 | 2.2 | 2.2 | 2.2 |
For the PRLB stock predictions from the analysts covering Proto Labs Inc, we have collected all of the individual PRLB stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering PRLB (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since PRLB stock predictions may vary widely, another useful metric to consider is the median PRLB stock prediction, which represents the price at which half of the analysts
made PRLB stock predictions that were higher and half made PRLB stock predictions that were lower. This makes for a different take on the PRLB stock predictions out there, as compared to average or mean.
And that median across all the individual PRLB stock predictions was: $40.0 as of 2025-01-24.
The very highest of the PRLB stock predictions for one year price target was $45.0, while the very lowest of the PRLB stock predictions in the analyst group was
$36.0 (with a standard deviation of $4.509). Get the latest Zacks research report on PRLB — FREE
Find out: PRLB next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
SSSS Stock Predictions
CNS Stock Predictions
FPI Stock Predictions
RVI Stock Predictions
HOFT Stock Predictions
DX Stock Predictions
IBIO Stock Predictions
SOL Stock Predictions
ONEM Stock Predictions
|
|
Buy (2.80 out of 4) 19th percentile
(ranked lower than approx. 81% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |